Insulet PODD
NASDAQ PODD
$148.93 -2.57 (-1.70%)
At close: Aug 20, 2026 · 2:22 PM UTC

Insulet (PODD) Cash from Financing Activities (2010 - 2026)

Insulet's (PODD) quarterly Cash from Financing Activities came in at -$319.9 million in Q1 2026, down 215.2% YoY from $277.7 million in Q1 2025, and down 341.24% on a QoQ basis from -$72.5 million in Q4 2025.

Insulet (PODD) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Insulet (PODD) has 17 years of Cash from Financing Activities data on file, last reported at -$319.9 million in Q1 2026.

  • Quarterly Cash from Financing Activities fell 215.2% year-over-year to -$319.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.2 billion (down 552.2% YoY) and the FY2025 annual result came in at -$595.3 million, down 2026.07% from the prior year.
  • Cash from Financing Activities fell to -$319.9 million in Q1 2026, from -$72.5 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $277.7 million in Q1 2025 to a low of -$457.0 million in Q3 2025.
  • A 5-year average of -$58.7 million and a median of -$12.1 million in 2023 frame the typical range for Cash from Financing Activities.
  • The widest YoY moves for Cash from Financing Activities: up 2069.5% in 2025, down 23952.63% in 2025.
  • Tracing PODD's Cash from Financing Activities over 5 years: stood at -$14.5 million in 2022, then surged by 115.17% to $2.2 million in 2023, then tumbled by 1045.45% to -$20.8 million in 2024, then sank by 248.56% to -$72.5 million in 2025, then slumped by 341.24% to -$319.9 million in 2026.
  • The last three Cash from Financing Activities figures came in at -$319.9 million (Q1 2026), -$72.5 million (Q4 2025), and -$457.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 199.49 Bn 193.88 Bn 7.27 Bn -3.52 Bn
2 Stryker 127.80 Bn 124.32 Bn 4.50 Bn -95.00 Mn
3 Medtronic 118.98 Bn 109.76 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 73.58 Bn 73.04 Bn 3.85 Bn -410.00 Mn
5 Edwards Lifesciences 51.93 Bn 47.68 Bn 1.35 Bn -300,000.00
6 Dexcom 34.34 Bn 32.39 Bn 830.00 Mn -607.30 Mn
7 GE HealthCare Technologies 33.76 Bn 31.66 Bn 2.18 Bn -236.00 Mn
8 Koninklijke Philips 26.37 Bn 23.05 Bn 4.55 Bn -1.34 Bn
9 Steris 23.07 Bn 22.59 Bn 684.20 Mn -213.50 Mn
10 Insulet 10.34 Bn 9.80 Bn 562.60 Mn 4.00 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 4.00 Mn
Jun 30, 2026 4.00 Mn
Mar 31, 2026 -319.90 Mn
Mar 31, 2026 -319.90 Mn
Dec 31, 2025 -72.50 Mn
Dec 31, 2025 -72.50 Mn
Sep 30, 2025 -457.00 Mn
Sep 30, 2025 -457.00 Mn
Jun 30, 2025 -343.50 Mn
Jun 30, 2025 -343.50 Mn
Mar 31, 2025 277.70 Mn
Mar 31, 2025 277.70 Mn
Dec 31, 2024 -20.80 Mn
Dec 31, 2024 -20.80 Mn
Sep 30, 2024 -1.90 Mn
Sep 30, 2024 -1.90 Mn
Jun 30, 2024 8.80 Mn
Jun 30, 2024 8.80 Mn
Mar 31, 2024 -14.10 Mn
Mar 31, 2024 -14.10 Mn